Last reviewed · How we verify

NCT04582760: EVER

Early Mobilization in Ventilated SEpsis & Acute Respiratory Failure Study

Completed NA Last updated 3 January 2025
What this trial tests

NA trial testing early mobilization in Early Mobility in 200 participants. Completed in 31 October 2024.

Timeline
11 September 2020
Primary endpoint
31 October 2024
31 October 2024

Quick facts

Lead sponsorSamsung Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment200
Start date11 September 2020
Primary completion31 October 2024
Estimated completion31 October 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Samsung Medical Center

Who can join

18 and older, any sex, with Early Mobility or Critically Ill. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Early mobilization in Ventilated sEpsis \& acute Respiratory failure Study: EVER Study

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of early mobilization on long-term dyadic mental health after critical illness.
    Kang J, Kang D, Chung CR, Hong SK, et al · · 2026 · PMID 42050608 · DOI 10.1186/s13054-026-06053-2

Verify or expand the search:

Other trials of early mobilization

Trials testing the same drug.

Other Samsung Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04582760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing